Literature DB >> 25258115

State of the art: cardiac transplantation.

Margot K Davis1, Sharon A Hunt2.   

Abstract

Recent advances in the management of heart transplant recipients have resulted in improved survival, particularly in the early post-transplant period. Although graft rejection, infection, malignancy, and allograft vasculopathy remain important challenges to the long-term management of heart transplant recipients, active research in these fields continues to advance our understanding and improve outcomes. This review will provide an overview of modern heart transplantation, summarize our current understanding of best practices for the management of heart transplant recipients, and describe recent advances in the field and areas of active research.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25258115     DOI: 10.1016/j.tcm.2014.08.004

Source DB:  PubMed          Journal:  Trends Cardiovasc Med        ISSN: 1050-1738            Impact factor:   6.677


  4 in total

1.  Myocardial tissue remodeling after orthotopic heart transplantation: a pilot cardiac magnetic resonance study.

Authors:  Otavio Rizzi Coelho-Filho; Ravi Shah; Carlos Fernando Ramos Lavagnoli; Jose Carlos Barros; Tomas G Neilan; Venkatesh L Murthy; Pedro Paulo Martins de Oliveira; Jose Roberto Matos Souza; Elaine Soraya Barbosa de Oliveira Severino; Karlos Alexandre de Souza Vilarinho; Lindemberg da Mota Silveira Filho; Jose Garcia; Marc J Semigran; Otavio Rizzi Coelho; Michael Jerosch-Herold; Orlando Petrucci
Journal:  Int J Cardiovasc Imaging       Date:  2016-07-20       Impact factor: 2.357

2.  miR-21 antagonism reprograms macrophage metabolism and abrogates chronic allograft vasculopathy.

Authors:  Vera Usuelli; Moufida Ben Nasr; Francesca D'Addio; Kaifeng Liu; Andrea Vergani; Basset El Essawy; Jun Yang; Emma Assi; Mayuko Uehara; Chiara Rossi; Anna Solini; Annalisa Capobianco; Elena Rigamonti; Luciano Potena; Massimo Venturini; Mario Sabatino; Lorena Bottarelli; Enrico Ammirati; Maria Frigerio; Eduardo Castillo-Leon; Anna Maestroni; Cinzia Azzoni; Cristian Loretelli; Andy Joe Seelam; Albert K Tai; Ida Pastore; Gabriella Becchi; Domenico Corradi; Gary A Visner; Gian V Zuccotti; Nelson B Chau; Reza Abdi; Marcus G Pezzolesi; Paolo Fiorina
Journal:  Am J Transplant       Date:  2021-05-03       Impact factor: 9.369

3.  Infectious complications following heart transplantation in the era of high-priority allocation and extracorporeal membrane oxygenation.

Authors:  Stéphanie Pons; Romain Sonneville; Lila Bouadma; Lenka Styfalova; Stéphane Ruckly; Mathilde Neuville; Aguila Radjou; Jordane Lebut; Marie-Pierre Dilly; Bruno Mourvillier; Richard Dorent; Patrick Nataf; Michel Wolff; Jean-François Timsit
Journal:  Ann Intensive Care       Date:  2019-01-25       Impact factor: 6.925

4.  CYP3A-status is associated with blood concentration and dose-requirement of tacrolimus in heart transplant recipients.

Authors:  Máté Déri; Zsófia Szakál-Tóth; Ferenc Fekete; Katalin Mangó; Evelyn Incze; Annamária Minus; Béla Merkely; Balázs Sax; Katalin Monostory
Journal:  Sci Rep       Date:  2021-11-01       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.